Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism Cyclin-K degraders(cyclin K degraders), CDK12 inhibitors(cyclin dependent kinase 12 inhibitors), CDK13 inhibitors(CHED protein kinase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Carrick Therapeutics Ltd.Startup |
Active Organization Carrick Therapeutics Ltd.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | IE | Carrick Therapeutics Ltd.Startup | - |